Pregled bibliografske jedinice broj: 535566
Angiotensin-Converting Enzyme Gene Polymorphism in Patients with Multiple Sclerosis from Bosnia and Herzegovina
Angiotensin-Converting Enzyme Gene Polymorphism in Patients with Multiple Sclerosis from Bosnia and Herzegovina // Genetic testing and molecular biomarkers, 15 (2011), 11; 835-838 doi:10.1089/gtmb.2010.0257 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 535566 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Angiotensin-Converting Enzyme Gene Polymorphism in Patients with Multiple Sclerosis from Bosnia and Herzegovina
Autori
Klupka-Sarić, Inge ; Peterlin, Borut ; Lovrečić, Luca ; Sinanović, Osman ; Vidović, Marija ; Šehanović, Aida ; Starčević Čizmarević, Nada ; Sepčić, Juraj ; Kapović, Miljenko ; Ristić, Smiljana
Izvornik
Genetic testing and molecular biomarkers (1945-0265) 15
(2011), 11;
835-838
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
ACE I/D; gene polymorphism; multiple sclerosis; susceptibility gene
Sažetak
Increased activity of angiotensin-converting enzyme (ACE) in the blood and cerebrospinal fluid of patients with multiple sclerosis (MS), and the inhibition of ACE in experimental autoimmune encephalomyelitis, suggested that ACE may play a role in the pathogenesis and progression of MS. We recently published the first report on the potential association of MS and ACE I/D polymorphism in Slovenian and Croatian patients with MS, in which it was shown that the DD genotype might contribute to a higher risk of developing MS in men. To confirm these findings in a similar ethnic population, we analyzed ACE I/D gene polymorphism in patients with MS from Bosnia and Herzegovina. One hundred and seventy patients with MS and 170 healthy controls were genotyped by the polymerase chain reaction method. There was no significant difference in the distribution of ACE I/D genotypes (p=0.783) or in the allelic frequencies (p=0.538) between patients with MS and control subjects. When patients with MS were stratified by sex, no statistically significant differences in allele or genotype distributions were observed. Finally, there was no indication of an impact of the ACE I/D genotype on disease course or severity. The ACE I/D polymorphism is not a risk factor for development of MS, nor does it contribute to disease severity in this Bosnia and Herzegovina population.
Izvorni jezik
Engleski
POVEZANOST RADA
Projekti:
062-1962766-0470 - Genetička analiza multiple skleroze (Ristić, Smiljana, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Rijeka
Profili:
Juraj Sepčić
(autor)
Nada Starčević Čizmarević
(autor)
Smiljana Ristić
(autor)
Miljenko Kapović
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE